Solutions for Infectious Diseases Control, Disease and Infection Control

Types Of Solutions for Infectious Disease Control

Respiratory Pathogens Nucleic Acid Detection

Using microfluidic technology, it’s widely used in pathogen screening of patients with respiratory infection symptoms, shortening treatment cycles and providing a scientific basis for clinical medication.

MAPMI Ultra-Broad-Spectrum Pathogen mNGS Test

Utilizing BES 4000 sequencing platform, MAPMI can screen 31,400 pathogenic microorganisms from clinical samples like blood, alveolar lavage fluid, cerebrospinal fluid, sputum, chest ascites, urine, secretions, and tissues.

Mycobacteria Nucleic Acid Detection

Real-time fluorescence PCR technology and TaqMan probe technology are used to distinguish between MTB and NTM.

Mycobacteria Species Identification

The rapid identification of 17 clinically important mycobacterial species enables precise targeting of pathogenic strain types.

MTB Drug Resistant Detection

MDR-TB disease can be quickly diagnosed by using gene chip technology to quickly test for resistance to rifampicin and isoniazid, two of the most important first-line anti-TB drugs.

Human Papillomavirus (HPV) Genotyping Detection

Based on microarray technology, it is used for simultaneous testing of 18 high-risk strains and 4 low-risk strains of HPV.

Six Respiratory Viruses Nucleic Acid Test Kit (PCR-Melting Curve Method)

This kit is used for detecting 6 common respiratory viruses, including influenza A virus, influenza B virus, respiratory syncytial virus, human rhinovirus, adenovirus, and SARS-CoV-2.

Respiratory System Infection Pathogen Targeted Next-generation Sequencing (tNGS) Kit

Respiratory System Infection Pathogen Targeted Next-generation Sequencing (tNGS) is an accurate detection method that combines the advantages of ultra-high multiplex target amplification and high-throughput sequencing technology.

Respiratory Virus Nucleic Acid Detection

Using isothermal amplification technology, which is based on the synergistic impact of reverse transcription and transcriptase, the reaction is conducted at 41 °C, and a specialized fluorescent probe is employed for real-time fluorescent detection. When combined with the microfluidic platform, it can find six common respiratory viruses, including SARS-CoV-2.

Respiratory Virus Nucleic Acid Detection

Why Choose CapitalBiotech?

Multiple options to pick from and a vast selection of products
Have been on the Chinese market for about 20 years, and there is ample clinical data to support its use
The R&D staff hails from Tsinghua University, where the emphasis is placed on cutting-edge technology
Each individual client’s needs can be individually met with a tailored set of solutions